You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IV anal cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gather Information About Rivaroxaban in United Kingdom Who Have

Completed
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Multiple Locations, United Kingdom
    Many locations
Sep 19, 2022

Vasoactive-inotropic Support and Levosimendan Use After Lung

Completed
  • Lung Transplant; Complications
  • Epinephrine Norepinephrine Dobutamine Dopamine Levosimendan
  • Milan, Italy
    Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Jan 27, 2023

Tumor Budding in Colorectal Cancer Under Different MMR Status

Completed
  • Tumor Budding
  • Rectal Cancer
  • total mesorectal exicision
  • Guangzhou, Guangdong, China
    Department of colorectal surgery, the Sixth Affiliated Hospital,
Nov 8, 2022

Fit to Fight Childhood Cancer

Not yet recruiting
  • Pediatric Oncology
  • Exercise training
  • (no location specified)
May 16, 2023

Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise

Recruiting
  • Localized Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Best Practice
  • +4 more
  • Seattle, Washington
  • +1 more
Jan 9, 2023

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Smoking Cessation Trial in Buffalo (affect regulation training, health and lifestyle)

Completed
  • Smoking Cessation
  • affect regulation training
  • health and lifestyle
  • Buffalo, New York
    Research Institute on Addictions, University at Buffalo
Oct 12, 2022

Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +8 more
  • Polatuzumab Vedotin
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)

Active, not recruiting
Has Results
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

COPD Trial in Philadelphia (myAirvo3, Pulse oximeter)

Recruiting
  • COPD
  • myAirvo3
  • Pulse oximeter
  • Philadelphia, Pennsylvania
    Temple University
Feb 21, 2022

Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 2, 2023

Post Market Clinical Follow-up Study Venezia

Recruiting
  • Cervical Cancer
  • Advanced Gynecological Applicator configuration
  • Vienna, Austria
  • +2 more
Mar 2, 2021

Prostate Cancer, Prostate Tumors Trial run by the CC (ultrasound image-guided ablation device)

Suspended
  • Prostate Cancer
  • Prostate Neoplasms
  • ultrasound image-guided ablation device
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Localized Prostate Carcinoma Trial in Milan (prostate SBRT)

Not yet recruiting
  • Localized Prostate Carcinoma
  • prostate SBRT
  • Milan, MI, Italy
    San Raffaele Scientific Institute
Jun 29, 2023

Microbiome in Colorectal Cancer Subjects

Suspended
  • Cancer Colon
  • Gastrointestinal Disease
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 3, 2022

    Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)

    Not yet recruiting
    • Prostate Cancer Diagnosis
    • PSMA PET scan
    • +2 more
    • Los Angeles, California
      VA Greater Los Angeles Healthcare System
    Apr 20, 2023

    Lung Cancer Trial in Baton Rouge (Pioglitazone 45 mg, Placebo)

    Not yet recruiting
    • Lung Cancer
    • Pioglitazone 45 mg
    • Placebo
    • Baton Rouge, Louisiana
      Pennington Biomedical Research Center
    Jun 22, 2023

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +8 more
    Apr 5, 2022

    Breast Carcinoma Trial in Seattle (Exercise Intervention, Resting, Biomarker Analysis)

    Completed
    • Breast Carcinoma
    • Exercise Intervention
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2022

    Tumor Metastasis Trial in Canada, United Kingdom, United States (BI 754091, BI 754111, BI 836880)

    Active, not recruiting
    • Neoplasm Metastasis
    • BI 754091
    • +2 more
    • La Jolla, California
    • +16 more
    Jan 9, 2023

    Pathogenesis of Hematologic Malignancies

    Enrolling by invitation
    • Acute Leukemia
    • +3 more
    • blood draw, bone marrow procedure, or tissue biopsy
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 9, 2022

    Healthy Trial in London (Pozelimab, Cemdisiran)

    Completed
    • Healthy
    • London, United Kingdom
      Regeneron Research Site
    Jul 1, 2022

    Extrapulmonary Small Cell Neuroendocrine Carcinoma, Recurrent Extrapulmonary Small Cell Neuroendocrine Carcinoma, Recurrent

    Recruiting
    • Advanced Extrapulmonary Neuroendocrine Carcinoma
    • +3 more
    • Atezolizumab
    • +7 more
    • Phoenix, Arizona
    • +105 more
    Jan 24, 2023

    Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early

    Withdrawn
    • NSCLC
    • Non Small Cell Lung Cancer
    • Cesium-131 Brachytherapy Seed
    • New York, New York
      Weill Cornell Medical College
    Mar 25, 2021